Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Health-economic outcomes in hospital patients with medical-psychiatric comorbidity: A systematic review and meta-analysis

  • Luc Jansen ,

    Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

    l.jansen@erasmusmc.nl

    Affiliations Erasmus MC, University Medical Center Rotterdam, Department of Psychiatry, Rotterdam, the Netherlands, Zilveren Kruis Achmea, Department of Health Procurement, Leusden, the Netherlands

  • Maarten van Schijndel,

    Roles Conceptualization, Validation, Writing – review & editing

    Affiliations Erasmus MC, University Medical Center Rotterdam, Department of Psychiatry, Rotterdam, the Netherlands, Rijnstate Hospital, Department of Psychiatry, Arnhem, the Netherlands

  • Jeroen van Waarde,

    Roles Data curation, Formal analysis, Writing – review & editing

    Affiliation Rijnstate Hospital, Department of Psychiatry, Arnhem, the Netherlands

  • Jan van Busschbach

    Roles Supervision, Writing – review & editing

    Affiliation Erasmus MC, University Medical Center Rotterdam, Department of Psychiatry, Rotterdam, the Netherlands

Health-economic outcomes in hospital patients with medical-psychiatric comorbidity: A systematic review and meta-analysis

  • Luc Jansen, 
  • Maarten van Schijndel, 
  • Jeroen van Waarde, 
  • Jan van Busschbach
PLOS
x

Abstract

Background

Hospital inpatients often experience medical and psychiatric problems simultaneously. Although this implies a certain relationship between healthcare utilization and costs, this relationship has never been systematically reviewed.

Objective

The objective is to examine the extent to which medical-psychiatric comorbidities relate to health-economic outcomes in general and in different subgroups. If the relationship is significant, this would give additional reasons to facilitate the search for targeted and effective treatments for this complex population.

Method

A systematic review in Embase, Medline, Psycinfo, Cochrane, Web of Science and Google Scholar was performed up to August 2016 and included cross-references from included studies. Only peer-reviewed empirical studies examining the impact of inpatient medical-psychiatric comorbidities on three health-economic outcomes (length of stay (LOS), medical costs and rehospitalizations) were included. Study design was not an exclusion criterion, there were no restrictions on publication dates and patients included had to be over 18 years. The examined populations consisted of inpatients with medical-psychiatric comorbidities and controls. The controls were inpatients without a comorbid medical or psychiatric disorder. Non-English studies were excluded.

Results

From electronic literature databases, 3165 extracted articles were scrutinized on the basis of title and abstract. This resulted in a full-text review of 86 articles: 52 unique studies were included. The review showed that the presence of medical-psychiatric comorbidity was related to increased LOS, higher medical costs and more rehospitalizations. The meta-analysis revealed that patients with comorbid depression had an increased mean LOS of 4.38 days compared to patients without comorbidity (95% CI: 3.07 to 5.68, I2 = 31%).

Conclusions

Medical-psychiatric comorbidity is related to increased LOS, medical costs and rehospitalization; this is also shown for specific subgroups. This study had some limitations; namely, that the studies were very heterogenetic and, in some cases, of poor quality in terms of risk of bias. Nevertheless, the findings remain valid and justify the search for targeted and effective interventions for this complex population.

Introduction

Hospital inpatients often experience medical and psychiatric problems simultaneously. For patients who are admitted to hospitals for a general medical illness, the prevalence of a comorbid psychiatric disorder is estimated at 40% [1]. Conversely, psychiatric patients are at increased risk of developing comorbid general medical disorders [2]. The consequences of concurrent general medical and psychiatric illnesses include an increase in morbidity, mortality, healthcare utilization and costs [3]. All psychiatric disorders are associated with increased morbidity, and mortality and patients who suffer from eating disorders and substance dependence have the highest risk[47]. Numerous studies examined the relationship between medical-psychiatric comorbidities and health-economic outcomes. Most studies have evaluated the impact of comorbidities on three outcome measures: length of stay (LOS), medical costs and rehospitalization rates [812]. These parameters are considered major cost drivers in healthcare [13]. Although these studies suggest that medical-psychiatric comorbidities relate to health-economic outcomes, these outcomes have never been reviewed systematically. Furthermore, the nature of the relationship may be different for separate subgroups [8, 11, 14, 15]. Meta-analyses on this subject have not been performed and, therefore, the overall pooled effect of the relationship between medical-psychiatric comorbidities and health-economic outcomes remains unknown.

Aims of the study

The aims of our study were as follows: 1) a systematic review of the literature to examine the relationship between medical-psychiatric comorbidity and health-economic outcomes; 2) an examination of possible differences in health-economic outcomes in patient subgroups; 3) an examination of the pooled-effect sizes for the effects of medical-psychiatric comorbidities on LOS, medical costs and rehospitalizations using meta-analyses. The importance of this review lies in its contribution to a cost-effective treatment of this complex and expensive population [16]. Policy makers might use the estimation of pooled-effect sizes for the effects of medical-psychiatric comorbidity on the examined health-economic outcomes to improve the delivery of cost-effective care for patients with medical-psychiatric comorbidities. Furthermore, this review might stimulate future researchers to examine the impact of several subgroups with comorbidity on different health-economic outcomes more thoroughly.

Method

The literature was scrutinized by making queries in electronic literature databases and by examining cross-references in the included articles. Six electronic literature databases were examined: Embase, Medline, Cochrane, Psycinfo, Web of Science and Google Scholar. The data extraction was performed on March 3, 2015 by a biomedical information specialist and updated on August 1, 2016: the search terms used are shown in Table 1 and an example of a full electronic search is provided in Table 2. The search terms were adjusted to comply with the specifications of the different databases. Duplicates and non-English articles were removed. A literature search based on cross-referencing was performed on November, 27, 2015. As no new articles were included after updating the search on August 1, 2016, no new cross-referencing was performed after this point.

Inclusion criteria

Empirical studies that examine the effect of having either medical or psychiatric comorbidity in hospital inpatients are included. These hospital inpatients have to be either primarily medically or psychiatrically ill and aged 18 years or older. Studies had to measure the effect on any of three major health economic outcomes (length of stay and/or medical costs and/or rehospitalization), and must be published in a peer-reviewed journal. Any measure of LOS (days, mean, median, et cetera), all types of medical costs (direct and indirect), and all reports of rehospitalization (all relevant time-frames) were included as the aim was to broadly review the literature on these outcomes. Inclusion criteria were limited to these outcomes since these are most reported in literature. It was hypothesized that medical-psychiatric comorbidity has a significant impact on these outcomes; it was further expected that effects were most prominent for inpatients, because these patients are presumed to be the most severely ill. By focusing on these inclusion criteria, we aimed to decrease heterogeneity between included studies. Consequently, study design was not an exclusion criterion, there were no restrictions on publication dates. Additionally, the examined populations had to consist of inpatients with medical-psychiatric comorbidities and controls. The controls were required to be patients without a comorbid medical or psychiatric disorder; however, the way the controls were sampled was not an exclusion criterion. Non-English articles were excluded.

Ideally, a comparison of comorbid patients (disease A and B) with patients that only have disease A or only disease B would be made. In this way, discerning whether the effect was additive or multiplicative could be estimated. However, only inpatients with disease A or B were included and compared with disease AB for reasons of feasibility.

Selection procedure

Two authors (LAWJ and MAvS) independently assessed 100 randomly selected titles and abstracts to validate the inclusion criteria. All obtained articles were then reviewed on the basis of title and abstract by the first author. Full texts of the included articles were then obtained. Subsequently, two authors (LAWJ and JAvW) independently assessed the selected articles in a standardized manner to further include or exclude articles for the review. Consensus was sought when disagreements between the authors on inclusion existed. When no consensus could be reached, the assessment of a third author (MAvS) was decisive. An intra-class correlation coefficient was calculated to examine the accuracy of match between the reviewers.

Thereafter, two authors (LAWJ and JAvW) read all included articles and extracted relevant data about nine predetermined characteristics: study design, patient characteristics, somatic diagnoses, psychiatric diagnoses, control group, moment of data collection (during or after treatment), LOS, medical costs, and rehospitalization rates. An electronic spreadsheet (Microsoft Excel) was used with these predetermined characteristics and available information for every included article was recorded. Again, disagreements on the collected data were resolved by discussion and, if no consensus was reached, the assessment of a third author (MAvS) was decisive.

The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses was used to assess the risk of bias in each study [17]. The NOS scale has been developed to assess the quality of non-randomized studies with its design. It uses a “star system” that judges a study on three broad perspectives: selection of groups, comparability of groups, discernment of either the exposure or outcome of interest for case-control or cohort.

All included studies were rated by the first author (LAWJ) based on the NOS; using NOS, each article was rated on nine variables and could earn a maximum of “9 stars”. More stars indicates less risk of bias in the assessed article. Finally, in reporting this review, the “Preferred reporting Items for Systematic reviews and Meta-Analyses” (PRISMA) checklist [18] was used. A review protocol was not used a priori to this systematic review.

Subgroups were selected based on the number of studies that researched the specific subgroup. Only the most extensive researched subgroups per health-economic outcome are presented in this study.

Meta-analyses

Meta- analyses were performed using Review Manager 5.3. In studies that reported continuous data, only those that stated means and standard deviations were included in the analyses. Furthermore, pooled-effect sizes were only reported if the (sub-)population was reasonable homogenous as this is not appropriate for heterogeneous studies [19]. The heterogeneity was based on statistics where a cut-off point of an I2 of 50% was used. A random-effects model was applied to calculate treatment effects. In order to express treatment effects, the (standard) mean differences and 95% confidence intervals (CI) were calculated. The X2 test was used to determine the heterogeneity between included studies where I2 values of <25% represent low heterogeneity, between 25% and 50% represent moderate heterogeneity and values >50% suggest severe heterogeneity between the studies [20]. Statistical significance was assumed at P <0.05.

Results

Study selection

The systematic literature search resulted in a total of 6163 articles. After removing duplicates and non-English articles, a total of 3165 studies remained. After reviewing all studies on title and abstract, a total of 86 articles were included for the full-text review. The reviewing authors agreed on the inclusion of 36 articles and the exclusion of 37 articles; an intra-correlation coefficient of 0.76 between the reviewers was estimated. Consensus was not reached for thirteen articles; after discussion, eight of these were included and five excluded. References in all 44 included articles were cross-checked. This resulted in ten extra articles to review in full text, eight of which were included. These studies did not appear in the search since the title did not refer to medical-psychiatric comorbidity but to a specific disorder. Finally, after the selection procedure, a total of 52 articles entered the definite literature review (“Fig 1”).

A variety of study designs were included, mostly observational in nature. Longitudinal cohort study was the most common design. No randomized clinical trials were found.

All studies compared either a medical or psychiatric index disorder, 48 articles examined patients with a medical index disorder and a psychiatric comorbid disorder and, conversely, four articles examined atiens with a psychiatric index disorder and a medical comorbid disorder. The control groups consisted of inpatients without a medical or psychiatric comorbid disorder. The number of participants in the reviewed studies ranged from 63 to 1,617,710 patients. The impact of medical-psychiatric comorbidities on LOS was described in 42 (81%) articles, the impact on costs in 12 (23%) articles and on rehospitalization in ten (19%) articles. The risk of bias was assessed using the NOS and the scores ranged from the minimum (one star) to the maximum number (nine) of stars. Details of the individual studies are presented in Table 3, which is divided by outcome measure and sorted according to the NOS grading system. No additional risk of bias was performed: the risk of publication bias was low since both negative and positive findings were of interest for all measures (LOS, costs, rehospitalization).

thumbnail
Table 3. Impact of medical-psychiatric comorbidity on length of stay (LOS), medical cost and rehospitalization.

https://doi.org/10.1371/journal.pone.0194029.t003

Results of individual studies

Impact of medical-psychiatric comorbidities on LOS.

Table 3 shows the results of the 42 included studies that examined the impact of medical-psychiatric comorbidities on LOS. Articles with the least risk of bias are shown at the top of the table and are arranged according to the NOS grading system [8, 9, 11, 12, 15, 17, 2157]. LOS was increased in patients with medical-psychiatric comorbidities compared to patients without comorbidity in 40 out of 42 (95%) articles; in 33 (79%) studies, this relationship was statistically significant [8, 11, 15, 23, 25, 26, 2837, 3945, 4752, 5557]. In five (12%) articles, this relationship was non-significant [9, 12, 27, 46, 53] and in four (10%) articles, no information about statistical significance was given [21, 22, 24, 38]. The remaining two (5%) studies did not show a relationship [9, 24].

Nineteen (43%) of 42 studies provided data for meta-analysis “Fig 2”. The included studies appeared very heterogeneous: the range of the mean LOS in the comorbid group varied from 7.7–135.0 versus 7.2–69.8 in the control group. Because of this heterogeneity, the estimation of an overall pooled effect was not appropriate. Nevertheless, given that all results point in one direction, “Fig 2” shows that medical-psychiatric comorbidities are related to increased LOS.

thumbnail
Fig 2. Relation of medical-psychiatric comorbidity and length of stay (LOS) (because the study of Fulop et al. [1987] included two separate samples in two hospitals, both outcomes are included in the analyses).

https://doi.org/10.1371/journal.pone.0194029.g002

Impact of medical-psychiatric comorbidities on medical costs.

Table 3 shows the articles that described the impact of medical-psychiatric comorbidities on medical costs. Out of 12 studies, nine (75%) showed a significant relationship [8, 11, 29, 32, 36, 53, 5860] and three (25%) showed a non-significant relationship [10, 27, 59].

The results of five (42%) studies were included in a meta-analysis “Fig 3”. These studies were very heterogenous and, therefore, an estimate of an overall pooled effect was not applicable. However, “Fig 3” reveals that medical-psychiatric comorbidities are related to increased medical costs.

thumbnail
Fig 3. Relationship between medical-psychiatric comorbidity and medical costs.

https://doi.org/10.1371/journal.pone.0194029.g003

Impact of medical-psychiatric comorbidities on rehospitalization.

Table 3 shows the impact of medical-psychiatric comorbidities on rehospitalization. This relationship was described in ten (19%) studies [8, 9, 44, 45, 51, 6165]; of these, nine (90%) revealed that medical-psychiatric comorbidities related to increased rehospitalizations. Seven (70%) studies found a significant increase [[8, 9, 44, 51, 61, 62, 64], two (20%) noted a non-significant increase [45, 65] and one (10%) found neither an increase nor decrease [63]. A meta-analysis was not executed since the data could not be used in a meta-analysis.

Impact of different subgroups on health-economic outcomes.

In the reviewed studies, two subgroups–depression and delirium–appeared to be extensively studied and were suitable for further subgroup analysis.

Impact of comorbid depression and delirium on LOS.

The relationship between comorbid depression and LOS was examined in 16 out of 43 (37%) studies; of these, 11 studies (69%) showed a significant relationship [23, 25, 31, 33, 35, 36, 40, 47, 49, 50, 54]; two studies (13%) showed a non-significant relationship [38, 51], two (13%) no effect [22, 26] and one (6%) study demonstrated a non-significant relationship between shorter LOS and comorbid depression [34].

Six studies provided suitable data for meta-analysis; the overall pooled mean difference in “Fig 4” showed that patients with comorbid depression had an LOS that was 4.38 days longer than patients without comorbid depression (mean LOS: 4.38 days; 95% CI: 3.07 to 5.68 days). The weighted average mean LOS of the depressed group was 13.8 days as opposed to 10.5 days for the non-depressed group.

thumbnail
Fig 4. Meta-analysis in the subgroup depression examining the impact on length of stay (LOS).

https://doi.org/10.1371/journal.pone.0194029.g004

Another extensively studied subgroup consisted of patients with comorbid delirium. Seven (16%) articles found a relationship between comorbid delirious patients and increased LOS compared to patients without comorbid delirium; five studies (71%) showed a significant relationship [32, 37, 42, 45, 52] and two studies (29%) a non-significant relationship [41, 51]. The data in these articles were not sufficient to perform a meta-analysis.

Impact of comorbid depression on medical costs.

The relationship between comorbid depression and medical costs was examined in six (46%) studies; of these, five (92%) showed significantly higher medical costs in comorbid depressed patients compared to patients without comorbid depression [29, 36, 53, 58, 60]. One (8%) study indicated a non-significant relationship [32]. A meta-analysis was not performed as only two articles provided limited data.

Impact of comorbid depression on rehospitalization.

The relationship between medical-psychiatric comorbidities and rehospitalization was, again, extensively examined in the subgroup with comorbid depression compared to patients without comorbid depression. This was described explicitly in four (40%) reviewed articles. Two (50%) studies found that the odds ratio for rehospitalization was significantly higher in patients with comorbid depression [51, 64]. Another study (25%) showed that patients with comorbid depression and a history of prior hospitalizations within six months were three times more likely to be rehospitalized within 90 days [61]. One (25%) study did not find a significant increase of the odds ratio for rehospitalization in patients with comorbid depression [63]. Meta-analysis for this subgroup was not possible because only one article provided useful data.

Discussion

To our knowledge this is the first review that examined the relationship between medical-psychiatric comorbidity and health-economic outcomes. Our analysis shows that hospital inpatients having medical-psychiatric comorbidities have a longer LOS, higher medical costs and more rehospitalizations. No randomized trials were found, however, and only one included study reached the highest standardized NOS quality score. The pooled-effect measures were often not appropriate to interpret since the available studies were very heterogeneous [19]. Nevertheless, the (standardized) mean differences of all meta-analyses indicate that medical-psychiatric comorbidity is indeed related to increased health-economic outcomes. Moreover, the subgroup of depressed patients shows an increased mean LOS of 4.38 days compared to patients without depression: this outcome was moderately heterogeneous (I2 = 31%) and was therefore considered appropriate.

Policy and clinical implications

Our systematic literature review elucidates the importance of medical-psychiatric comorbidities on health-economic outcomes. It is, consequently, disappointing to find that the quality of the included studies was mostly limited and that the heterogeneity of study samples was huge. Future studies on quality improvement strategies should therefore examine the impact of medical-psychiatric comorbidities on health-economic outcomes. This will help care providers and policy makers to organize care for patients with medical-psychiatric comorbidity in the most efficient way.

Our literature review suggests that the depressed subgroup of medical-psychiatric comorbid patients has stronger relationships with health-economics outcomes in comparison to non-depressed patients. For the first time in literature, we have established that, on average, hospital inpatients with comorbid depression stay in the hospital 4.38 days longer than non-depressed patients. In the Netherlands, the costs of a medical inpatient day range from €435 to €575 [66]. Based on the results of our review, the average medical costs in this country for patients with comorbid depression are increased to €1905-€2520 compared to patients without comorbidity. Researchers, care providers, policy makers and health insurers might use these outcomes for future research and healthcare policy making to improve cost-effective care for this subgroup. Furthermore, future prospective and randomized research should examine the impact of specific subgroups on health-economic outcomes more thoroughly to help hospitals improve cost-effective care for different subgroups with medical-psychiatric comorbidity.

Limitations

Although a thorough and extensive electronic search was performed on 6163 titles, this systematic literature review had several limitations.

First, the included studies were highly heterogenic regarding the patient population, type of hospital, country and year; thus, the results were difficult to compare, which reduced the possibility of investigating a pooled effect. Therefore, the magnitude of the impact on health-economic outcomes remains uncertain.

Ideally, patients with medical-psychiatric comorbidity were compared to studies that examined the medical and psychiatric illness separately. In this way, it might be possible to examine whether the effect of different combinations of medical and psychiatric illness was additive or multiplicative. For reasons of feasibility, our search strategy was narrowed to the impact of medical-psychiatric comorbidity on inpatients (as opposed to inpatients without psychiatric comorbidity) on health-economic outcomes. It was anticipated that including all possible combinations of general medical and psychiatric illnesses in the search would lead to an unmanageable number of included papers.

Second, in the past decades, the average LOS in hospitals has been largely reduced, which made it harder to compare studies over time. Publication date was not an exclusion criterion; hence, some studies were published more than two decades ago. As such, the results in these studies could reflect hospital-care patterns that have since changed.

Next, the search in the literature list led to the inclusion of eight extra titles. These titles were not found in the extensive search strategy since they described a specific disorder and the focus of the search was on medical-psychiatric comorbidity in general. While developing the electronic search strategy, it was explicitly decided to not include specific disorders since there was no clear cut-off point to determine when to stop including specific disorders in the search terms. Furthermore, if all disorders that exist in the literature were included in the search, the results of the literature search would be too broad.

Subsequently, the studies that examined medical costs had some methodological variation in terms of sampling and reporting those costs. Some studies examined the impact of total costs (inpatient, outpatient, pharmacy) and some only the in-hospital costs. Nevertheless, the evidence of almost all studies concerning the relationship between medical costs and medical-psychiatric comorbidities pointed in the same direction. Consequently, it was suggested that comorbidity had an increasing effect on medical costs.

Moreover, the quality of the reviewed studies was variable and only one study received the full nine stars on the NOS. [17] Thus, the strength of the evidence differed among the three health-economic outcomes. Most studies examined the impact of medical-psychiatric comorbidities on LOS. As 95% of these studies showed an increased LOS, this relationship with medical-psychiatric comorbidities seemed the most reliable.

Another limitation of our study was that only one author rated the included articles. However, since almost all individual articles found results that pointed in the same direction, the risk of bias in the studies did not seem to impact the overall findings of this review. Additionally, there is a possible publication bias since only peer-reviewed articles were included. A study protocol was not developed in advance of this systematic review; it would therefore be challenging to note deviations and to assess if the outcomes of the review are reported according to the original study plan.

Finally, two subgroups of patients (comorbid depression and delirium) were comprehensively researched and therefore the results of studies that described these subgroups were used in the meta-analysis. This analysis was not predetermined but carried out post hoc since these groups appeared to be the most extensively studied in the included papers. Since the search was not focused on these subgroups, some literature that describes the impact of depression and a somatic comorbidity on health-economic outcomes may have been overlooked. Nevertheless, future researchers can use the results of this research to examine the impact of subgroups with a specific psychiatric disorder and a medical comorbidity.

Despite these limitations, the main conclusions of this review remain valid and clearly indicate, firstly, that general hospital inpatients with medical-psychiatric comorbidities showed longer LOS, higher medical costs and more rehospitalizations and, secondly, that the subgroup of depressed patients showed an increased mean LOS of 4.38 days compared to patients without depression.

Conclusion

This systematic literature review found a relationship between medical-psychiatric comorbidities and health-economic outcomes (LOS, medical costs and rehospitalizations). The meta-analysis for the subgroup depression showed an increased LOS (on average 4.38 days longer inpatient stay) compared to patients without depression. These results demonstrate that, on average, the medical costs for this subgroup are between €1905 and €2550 higher than patients without a comorbid depression. Policy makers might use these results to improve cost-effective care for this subgroup. Based on our results, we suggest that future research should examine the impact of several subgroups with medical-psychiatric comorbidity on health-economic outcomes more thoroughly.

Acknowledgments

Funding/Support: No financial or material support was obtained and no persons without authorship contributed to the writing of this article.

Conflicts of Interest disclosure: There were no conflicts of interest for Luc Jansen, Maarten van Schijndel, Jeroen van Waarde and Jan van Busschbach.

References

  1. 1. Van Waarde J. A., et al. "De medisch-psychiatrische unit: meerwaarde voor patiënten, artsen en ziekenhuizen." Nederlands tijdschrift voor geneeskunde 148.5 (2004): 209–211.
  2. 2. Kathol Roger, et al. "Epidemiologic trends and costs of fragmentation." Medical Clinics of North America 90.4 (2006): 549–572. pmid:16843762
  3. 3. Abbate-Daga G., Delsedime N., Nicotra B., Giovannone C., Marzola E., Amianto F., et al. Psychosomatic syndromes and anorexia nervosa. BMC Psychiatry. 2013;13.
  4. 4. Doherty A. M., Gaughran F. The interface of physical and mental health. Social Psychiatry and Psychiatric Epidemiology. 2014;49(5):673–82. pmid:24562320
  5. 5. Harris E. C., Barraclough B. Excess mortality of mental disorder. The British Journal of Psychiatry. 1998;173(1):11–53.
  6. 6. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M. R., et al. No health without mental health. The lancet. 2007;370(9590):859–77.
  7. 7. Gur S., Weizman S., Stubbs B., Matalon A., Meyerovitch J., Hermesh H., et al. Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study. Psychiatry Research. 2018;260:177–81.
  8. 8. Adams L. Y., Koop P., Quan H., Norris C. A population-based comparison of the use of acute healthcare services by older adults with and without mental illness diagnoses. J Psychiatr Ment Health Nurs. 2015;22(1):39–46. pmid:25430792
  9. 9. Chwastiak L. A., Davydow D. S., McKibbin C. L., Schur E., Burley M., McDonell M. G., et al. The Effect of Serious Mental Illness on the Risk of Rehospitalization Among Patients With Diabetes. Psychosomatics. 2014;55(2):134–43. pmid:24367898
  10. 10. Haas L., Stargardt T., Schreyoegg J., Schlosser R., Danzer G., Klapp B. F. Inpatient costs and predictors of costs in the psychosomatic treatment of anorexia nervosa. Int J Eating Disord. 2012;45(2):214–21.
  11. 11. Hochlehnert A., Niehoff D., Wild B., Junger J., Herzog W., Lowe B. Psychiatric comorbidity in cardiovascular inpatients: Costs, net gain, and length of hospitalization. J Psychosom Res. 2011;70(2):135–9. pmid:21262415
  12. 12. Ismail Z., Arenovich T., Granger R., Grieve C., Willett P., Patten S., et al. Associations of medical comorbidity, psychosis, pain, and capacity with psychiatric hospital length of stay in geriatric inpatients with and without dementia. Int Psychogeriatr. 2014:1–9.
  13. 13. Drummond Michael F., et al. Methods for the economic evaluation of health care programmes. Oxford university press, 2015.
  14. 14. Kathol Roger G., et al. "General medical and pharmacy claims expenditures in users of behavioral health services." Journal of General Internal Medicine 20.2 (2005): 160–167. pmid:15836550
  15. 15. Bourgeois J. A., Wegelin J. A. Lagtime in psychosomatic medicine consultations for cognitive-disorder patients: association with length of stay. Psychosomatics. 2009;50(6):622–5. pmid:19996234
  16. 16. Kishi Yasuhiro, and Kathol Roger G. "Integrating medical and psychiatric treatment in an inpatient medical setting: the type IV program." Psychosomatics 40.4 (1999): 345–355. pmid:10402882
  17. 17. Wells G. A., et al. "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses." (2000).
  18. 18. Liberati Alessandro, et al. "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration." Annals of internal medicine 151.4 (2009): W-65.
  19. 19. Rotter Thomas, et al. "A systematic review and meta-analysis of the effects of clinical pathways on length of stay, hospital costs and patient outcomes." BMC health services research 8.1 (2008): 1.
  20. 20. Higgins J. P., et al. "Measuring inconsistency in meta-analyses." Bmj 327.7414 (2003): 557–560. pmid:12958120
  21. 21. Mai Q., Holman C. D. J., Sanfilippo F. M., Emery J. D. The impact of mental illness on potentially preventable hospitalisations: A population-based cohort study. BMC Psychiatry. 2011;11.
  22. 22. Furlanetto L. M., Da Silva R. V., Bueno J. R. The impact of psychiatric comorbidity on length of stay of medical inpatients. Gen Hosp Psychiatry. 2003;25(1):14–9. pmid:12583922
  23. 23. Bressi S. K., Marcus S. C., Solomon P. L. The impact of psychiatric comorbidity on general hospital length of stay. Psychiatr Q. 2006;77(3):203–9. pmid:16958003
  24. 24. Hansen M. S., Fink P., Frydenberg M., de Jonge P., Huyse F. J. Complexity of care and mental illness in medical inpatients. Gen Hosp Psych. 2001;23(6):319–25.
  25. 25. Saravay S. M., Steinberg M. D., Weinschel B., Pollack S., Alovis N. Psychological Comorbidity and Length of Stay in the General-Hospital. Am J Psychiat. 1991;148(3):324–9. pmid:1992834
  26. 26. Bourgeois J. A., Kremen W. S., Servis M. E., Wegelin J. A., Hales R. E. The impact of psychiatric diagnosis on length of stay in a university medical center in the managed care era. Psychosomatics. 2005;46(5):431–9. pmid:16145188
  27. 27. Benzer J. K., Sullivan J. L., Williams S., Burgess J. F. One-Year Cost Implications of Using Mental Health Care After Discharge From a General Medical Hospitalization. Psychiatr Serv. 2012;63(7):672–8. pmid:22555279
  28. 28. Fulop G., Strain J. J., Fahs M. C., Hammer J. S., Lyons J. S. Medical disorders associated with psychiatric comorbidity and prolonged hospital stay. HOSP COMMUNITY PSYCHIATRY. 1989;40(1):80–2. pmid:2912843
  29. 29. Levenson James L., Hamer Robert M., and Rossiter Louis F. "Relation of psychopathology in general medical inpatients to use and cost of services." Am J Psychiatry 147.11 (1990): 1498–1503. pmid:2121054
  30. 30. Fulop G., Strain J. J., Vita J., Lyons J. S. Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report. Am J …. 1987.
  31. 31. Schubert D. S. P. Impact of the interaction of depression and physical illness on a psychiatric unit's length of stay. GEN HOSP PSYCHIATRY. 1995;17(5):326–34. pmid:8522147
  32. 32. Zatzick D. F., Kang S. M., Kim S. Y., Leigh P., Kravitz R., Drake C., et al. Patients with recognized psychiatric disorders in trauma surgery: Incidence, inpatient length of stay, and cost. J Trauma Inj Infect Crit Care. 2000;49(3):487–95.
  33. 33. Koenig H. G., Kuchibhatla M. Use of health services by hospitalized medically III depressed elderly patients. Am J Psychiatry. 1998;155(7):871–7. pmid:9659849
  34. 34. Fulop G., Strain J. J., Fahs M. C., Schmeidler J., Snyder S. A prospective study of the impact of psychiatric comorbidity on length of hospital stays of elderly medical-surgical inpatients. Psychosomatics. 1998;39(3):273–80. pmid:9664774
  35. 35. Hosaka Takashi, et al. "Comorbidity of depression among physically ill patients and its effect on the length of hospital stay." Psychiatry and clinical neurosciences 53.4 (1999): 491–495. pmid:10498231
  36. 36. Sayers Steven L., et al. "Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure." Journal of the American Geriatrics Society 55.10 (2007): 1585–1591. pmid:17714458
  37. 37. Smith P. J., Rivelli S. K., Waters A. M., Hoyle A., Durheim M. T., Reynolds J. M., et al. Delirium affects length of hospital stay after lung transplantation. J Crit Care. 2014.
  38. 38. Wancata J., Benda N., Windhaber J., Nowotny M. Does psychiatric comorbidity increase the length of stay in general hospitals? Gen Hosp Psychiatry. 2001;23(1):8–14. pmid:11226551
  39. 39. Ceilley J. W., Douaihy A. B., Salloum I. M. Prevalence and impact of medical disorders in hospitalized psychiatric patients with comorbid substance use disorders. Addict Disord Treat. 2005;4(2):65–70.
  40. 40. Davydow D. S., Russo J. E., Ludman E., Ciechanowski P., Lin E. H. B., Von Korff M., et al. The Association of Comorbid Depression with Intensive Care Unit Admission in Patients with Diabetes: A Prospective Cohort Study. Psychosomatics. 2011;52(2):117–26. pmid:21397103
  41. 41. Bourgeois J. A., Hilty D. M., Wegelin J. A., Hales R. E. Cognitive-disorder diagnoses in inpatient psychosomatic-medicine consultations: Associations with age and length of stay. Psychosomatics. 2006;47(5):414–20. pmid:16959930
  42. 42. Stevens L. E., de Moore G. M., Simpson J. M. Delirium in hospital: does it increase length of stay? Aust N Z J Psych. 1998;32(6):805–8.
  43. 43. Uldall K. K., Koutsky L. A., Bradshaw D. H., Hopkins S. G., Katon W., Lafferty W. E. Psychiatric comorbidity and length of stay in hospitalized AIDS patients. AM J PSYCHIATRY. 1994;151(10):1475–8. pmid:7916541
  44. 44. Borckardt J. J., Madan A., Barth K., Galloway S., Balliet W., Cawley P. J., et al. Excess health care service utilization and costs associated with underrecognition of psychiatric comorbidity in a medical/surgical inpatient setting. Qual Manag Health Care. 2011;20(2):98–102. pmid:21467896
  45. 45. Boustani M., Baker M. S., Campbell N., Munger S., Hui S. L., Castelluccio P., et al. Impact and Recognition of Cognitive Impairment Among Hospitalized Elders. J Hosp Med. 2010;5(2):69–75. pmid:20104623
  46. 46. Morris Philip LP, and Goldberg Richard J. "Impact of psychiatric comorbidity on length of hospital stay in gastroenterology patients." General hospital psychiatry 12.2 (1990): 77–82. pmid:2307369
  47. 47. Verbosky L. A., Franco K. N., and Zrull J. P. "The relationship between depression and length of stay in the general hospital patient." The Journal of clinical psychiatry 54.5 (1993): 177–181. pmid:8509347
  48. 48. Erdur L., Kallenbach-Dermutz B., Lehmann V., Zimmermann-Viehoff F., Kopp W., Weber C., et al. Somatic comorbidity in anorexia nervosa: First results of a 21-year follow-up study on female inpatients. Biopsychosoc Med. 2012;6(1):4. pmid:22300749
  49. 49. Sloan D. M., Yokley J., Gottesman H., Schubert D. S. P. A five-year study on the interactive effects of depression and physical illness on psychiatric unit length of stay. Psychosom Med. 1999;61(1):21–5. pmid:10024064
  50. 50. Ackerman A. D., Lyons J. S., Hammer J. S., Larson D. B. The impact of coexisting depression and timing of psychiatric consultation on medical patients' length of stay. HOSP COMMUNITY PSYCHIATRY. 1988;39(2):173–6. pmid:3345980
  51. 51. Uldall K. K., Koutsky L. A., Bradshaw D. H., Krone M. Use of hospital services by AIDS patients with psychiatric illness. Gen Hosp Psychiatry. 1998;20(5):292–301. pmid:9788029
  52. 52. McCusker J., Cole M. G., Dendukuri N., Belzile E. Does delirium increase hospital stay? J Am Geriatr Soc. 2003;51(11):1539–46. pmid:14687382
  53. 53. Creed F., Morgan R., Fiddler M., Marshall S., Guthrie E. Depression and Anxiety Impair Health-Related Quality of Life and Are Associated With Increased Costs in General Medical Inpatient. Psychosomatics. 2002.
  54. 54. Schubert D. S. P., et al. "Increase of medical hospital length of stay by depression in stroke and amputation patients: a pilot study." Psychotherapy and psychosomatics 57.1–2 (1992): 61–66. pmid:1584900
  55. 55. Douzenis A., Seretis D., Nika S., Nikolaidou P., Papadopoulou A., Rizos E. N., et al. Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. BMC Health Serv Res. 2012;12:166. pmid:22713232
  56. 56. Johansen H., Fines P. Acute care hospital days and mental diagnoses. Health Rep. 2012;23(4):61–5. pmid:23356047
  57. 57. Mojet Eveline J., Hengeveld Michiel W., and Bouwhuis Marijke L. "Length of hospital stay of medical and surgical inpatients referred for psychiatric consultation: a retrospective study." The International Journal of Psychiatry in Medicine 19.3 (1990): 227–235.
  58. 58. Druss B. G., Rosenheck R. A. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatr Serv. 1999;50(2):214–8. pmid:10030479
  59. 59. Shen C., Sambamoorthi U., Rust G. Co-occurring mental illness and health care utilization and expenditures in adults with obesity and chronic physical illness. DIS MANAGE. 2008;11(3):153–60.
  60. 60. Welch C. A., Czerwinski D., Ghimire B., Bertsimas D. Depression and costs of health care. Psychosomatics. 2009;50(4):392–401. pmid:19687180
  61. 61. Kartha A., Anthony D., Manasseh C. S., Greenwald J. L., Chetty V. K., Burgess J. F. Jr, et al. Depression is a risk factor for rehospitalization in medical inpatients. Prim Care Companion J Clin Psych. 2007;9(4):256–62.
  62. 62. Saravay S. M., Pollack S., Steinberg M. D., Weinschel B., Habert M. Four-year follow-up of the influence of psychological comorbidity on medical rehospitalization. AM J PSYCHIATRY. 1996;153(3):397–403. pmid:8610829
  63. 63. Chang C. M., Lee Y., Lee Y., Yang M. J., Wen J. K. Predictors of readmission to a medical-psychiatric unit among patients with minor mental disorders. Chang Gung Med J. 2001;24(1):34–43. pmid:11299975
  64. 64. Jiang Wei, et al. "Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure." Archives of internal medicine 161.15 (2001): 1849–1856. pmid:11493126
  65. 65. Evans R. L., Hendricks R. D., Lawrence K. V. Effect of mental disorders on hospital readmission for medical/surgical patients. Psychological Reports. 1989;62(2):519–22.
  66. 66. Tan S. S., Bouwmans C. A., Rutten F. F., Hakkaart-van Roijen L. Update of the Dutch Manual for Costing in Economic Evaluations. Int J Technol Assess Health Care. 2012;28(2):152–8. pmid:22559757